ASSESSMENT OF ADVERSE DRUG REACTIONS FOLLOWING COVID-19 VACCINATION AMONG UNDERGRADUATE HEALTHCARE STUDENTS: A CROSS-SECTIONAL STUDY
International Journal of Pharmacological and Pharmaceutical Innovations (IJPPI) · 2026
DOI: 10.67540/ijppi.v1.i3.026 ↗Kurz gefasst
Querschnittstudie in der Zeitschrift International Journal of Pharmacological and Pharmaceutical Innovations (IJPPI), 2026. Verfasst von ANJU RUHELA.
Abstract (Originalsprache)
Objective
The present investigation aimed to examine adverse drug reactions (ADRs) reported after COVID-19 vaccination among undergraduate healthcare students. It also evaluated the occurrence, clinical characteristics, and duration of adverse events experienced following immunization.
Methods
A questionnaire-based descriptive cross-sectional study was conducted among undergraduate healthcare students of Gyani Inder Singh Institute of Professional Studies, Dehradun, Uttarakhand, India. A structured questionnaire consisting of 14 close-ended questions was used to collect demographic information, vaccination status, type of vaccine received, occurrence of adverse reactions, symptom duration, and post-vaccination outcomes. A total of 26 valid responses were included in the final analysis. Data were analyzed using descriptive statistics and expressed as numbers and percentages.
Results
Among the participants, 88.5% were pharmacy students and 96.2% were male. Covishield was the most commonly administered vaccine (84.6%), followed by Covaxin (11.5%). Most participants had completed booster-dose vaccination (65.4%). Adverse drug reactions following vaccination were reported by 80.8% of participants. The most common adverse reactions included pain at the injection site (69.2%), fever (53.8%), fatigue (50%), myalgia (46.2%), headache (38.5%), and chills (30.8%). Most symptoms resolved within one to four days. A small proportion of participants reported breakthrough COVID-19 infection after vaccination. No serious or life-threatening adverse reactions were reported.
Conclusion
The results suggest that COVID-19 vaccination had a favorable safety profile among undergraduate healthcare students. The reported adverse events were predominantly minor, resolved within a short period, and generally required no specific intervention. Nevertheless, continued monitoring of vaccine-related reactions and effective pharmacovigilance are important for identifying safety concerns, supporting reliable safety data, and sustaining confidence in vaccination programs.
Zitieren
APA
RUHELA, A. (2026). ASSESSMENT OF ADVERSE DRUG REACTIONS FOLLOWING COVID-19 VACCINATION AMONG UNDERGRADUATE HEALTHCARE STUDENTS: A CROSS-SECTIONAL STUDY. International Journal of Pharmacological and Pharmaceutical Innovations (IJPPI). https://doi.org/10.67540/ijppi.v1.i3.026
Vancouver
RUHELA A. ASSESSMENT OF ADVERSE DRUG REACTIONS FOLLOWING COVID-19 VACCINATION AMONG UNDERGRADUATE HEALTHCARE STUDENTS: A CROSS-SECTIONAL STUDY. International Journal of Pharmacological and Pharmaceutical Innovations (IJPPI). 2026. doi:10.67540/ijppi.v1.i3.026
BibTeX
@article{RUHELA2026,
author = {RUHELA, ANJU},
title = {ASSESSMENT OF ADVERSE DRUG REACTIONS FOLLOWING COVID-19 VACCINATION AMONG UNDERGRADUATE HEALTHCARE STUDENTS: A CROSS-SECTIONAL STUDY},
journal = {International Journal of Pharmacological and Pharmaceutical Innovations (IJPPI)},
year = {2026},
doi = {10.67540/ijppi.v1.i3.026}
}
EUVIMED